Race and ethnicity are associated with delays in breast cancer treatment (2003-2006)

Stacey A. Fedewa, Stephen B. Edge, Andrew K. Stewart, Michael Halpern, Nicole M. Marlow, Elizabeth M. Ward

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Access to timely treatment may be one contributing factor to survival differences by race/ethnicity among breast cancer patients. In this study, we examined the relationship between race and treatment delay among breast cancer patients diagnosed between 2003 and 2006 with Stage I-III breast cancer from the National Cancer Database (n5250,007).\ We evaluated factors associated with receipt of initial treatment more than 30, 60, and 90 days after biopsy using multivariable log binomial models to estimate risk ratios (RR) and 95% confidence intervals (CI). The average time to treatment was 34.30 days (±31.77). Independent of health insurance, stage at diagnosis, and age, Black and Hispanic patients had higher risks of 30, 60, and 90-day treatment delay compared with White patients. Further studies are needed to define the role of structural, health system, physician, clinical and patient factors in treatment delay among Black and Hispanic women and appropriate interventions.

Original languageEnglish (US)
Pages (from-to)128-141
Number of pages14
JournalJournal of Health Care for the Poor and Underserved
Volume22
Issue number1
StatePublished - Feb 2011
Externally publishedYes

Fingerprint

Breast Neoplasms
Hispanic Americans
Therapeutics
Statistical Models
Health Insurance
Odds Ratio
Databases
Confidence Intervals
Physicians
Biopsy
Survival
Health
Neoplasms

Keywords

  • Breast cancer
  • Health insurance
  • Race/ethnicity
  • Treatment delays

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Fedewa, S. A., Edge, S. B., Stewart, A. K., Halpern, M., Marlow, N. M., & Ward, E. M. (2011). Race and ethnicity are associated with delays in breast cancer treatment (2003-2006). Journal of Health Care for the Poor and Underserved, 22(1), 128-141.

Race and ethnicity are associated with delays in breast cancer treatment (2003-2006). / Fedewa, Stacey A.; Edge, Stephen B.; Stewart, Andrew K.; Halpern, Michael; Marlow, Nicole M.; Ward, Elizabeth M.

In: Journal of Health Care for the Poor and Underserved, Vol. 22, No. 1, 02.2011, p. 128-141.

Research output: Contribution to journalArticle

Fedewa, Stacey A. ; Edge, Stephen B. ; Stewart, Andrew K. ; Halpern, Michael ; Marlow, Nicole M. ; Ward, Elizabeth M. / Race and ethnicity are associated with delays in breast cancer treatment (2003-2006). In: Journal of Health Care for the Poor and Underserved. 2011 ; Vol. 22, No. 1. pp. 128-141.
@article{5d6d1c69fc834e36b447e87b73cb726d,
title = "Race and ethnicity are associated with delays in breast cancer treatment (2003-2006)",
abstract = "Access to timely treatment may be one contributing factor to survival differences by race/ethnicity among breast cancer patients. In this study, we examined the relationship between race and treatment delay among breast cancer patients diagnosed between 2003 and 2006 with Stage I-III breast cancer from the National Cancer Database (n5250,007).\ We evaluated factors associated with receipt of initial treatment more than 30, 60, and 90 days after biopsy using multivariable log binomial models to estimate risk ratios (RR) and 95{\%} confidence intervals (CI). The average time to treatment was 34.30 days (±31.77). Independent of health insurance, stage at diagnosis, and age, Black and Hispanic patients had higher risks of 30, 60, and 90-day treatment delay compared with White patients. Further studies are needed to define the role of structural, health system, physician, clinical and patient factors in treatment delay among Black and Hispanic women and appropriate interventions.",
keywords = "Breast cancer, Health insurance, Race/ethnicity, Treatment delays",
author = "Fedewa, {Stacey A.} and Edge, {Stephen B.} and Stewart, {Andrew K.} and Michael Halpern and Marlow, {Nicole M.} and Ward, {Elizabeth M.}",
year = "2011",
month = "2",
language = "English (US)",
volume = "22",
pages = "128--141",
journal = "Journal of Health Care for the Poor and Underserved",
issn = "1049-2089",
publisher = "Johns Hopkins University Press",
number = "1",

}

TY - JOUR

T1 - Race and ethnicity are associated with delays in breast cancer treatment (2003-2006)

AU - Fedewa, Stacey A.

AU - Edge, Stephen B.

AU - Stewart, Andrew K.

AU - Halpern, Michael

AU - Marlow, Nicole M.

AU - Ward, Elizabeth M.

PY - 2011/2

Y1 - 2011/2

N2 - Access to timely treatment may be one contributing factor to survival differences by race/ethnicity among breast cancer patients. In this study, we examined the relationship between race and treatment delay among breast cancer patients diagnosed between 2003 and 2006 with Stage I-III breast cancer from the National Cancer Database (n5250,007).\ We evaluated factors associated with receipt of initial treatment more than 30, 60, and 90 days after biopsy using multivariable log binomial models to estimate risk ratios (RR) and 95% confidence intervals (CI). The average time to treatment was 34.30 days (±31.77). Independent of health insurance, stage at diagnosis, and age, Black and Hispanic patients had higher risks of 30, 60, and 90-day treatment delay compared with White patients. Further studies are needed to define the role of structural, health system, physician, clinical and patient factors in treatment delay among Black and Hispanic women and appropriate interventions.

AB - Access to timely treatment may be one contributing factor to survival differences by race/ethnicity among breast cancer patients. In this study, we examined the relationship between race and treatment delay among breast cancer patients diagnosed between 2003 and 2006 with Stage I-III breast cancer from the National Cancer Database (n5250,007).\ We evaluated factors associated with receipt of initial treatment more than 30, 60, and 90 days after biopsy using multivariable log binomial models to estimate risk ratios (RR) and 95% confidence intervals (CI). The average time to treatment was 34.30 days (±31.77). Independent of health insurance, stage at diagnosis, and age, Black and Hispanic patients had higher risks of 30, 60, and 90-day treatment delay compared with White patients. Further studies are needed to define the role of structural, health system, physician, clinical and patient factors in treatment delay among Black and Hispanic women and appropriate interventions.

KW - Breast cancer

KW - Health insurance

KW - Race/ethnicity

KW - Treatment delays

UR - http://www.scopus.com/inward/record.url?scp=79951617667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951617667&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 128

EP - 141

JO - Journal of Health Care for the Poor and Underserved

JF - Journal of Health Care for the Poor and Underserved

SN - 1049-2089

IS - 1

ER -